InvestorsHub Logo
Followers 80
Posts 24654
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 07/21/2022 9:20:42 AM

Thursday, July 21, 2022 9:20:42 AM

Post# of 27575
NLSP - .5949 Pre-market .705/.71

NLS Pharmaceutics Announces Positive Opinion From European Regulators To Grant Orphan Drug Designation For Mazindol ER In Idiopathic Hypersomnia

https://stockcharts.com/h-sc/ui?s=nlsp
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.